Pfizer and UCSF form drug discovery alliance

In a novel experiment to advance new drug discovery and development, as well as stimulate basic research, global drug giant Pfizer and University of California San Francisco have launched a collaboration that spans many disciplines, several UC campuses and multiple Pfizer research units.

The three-year agreement, with research and other support up to $9.5 million, establishes a university team to help identify promising areas of mutual interest and facilitate project management. The innovative effort already has templates in place to allow swift industry-university agreements.